Search for a trial | Research with human participants

1 results

A phase 1/2a, first-in-human, open-label, multicenter, dose escalation study of MP0533 in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)

Approved WMORecruiting

This study has been transitioned to CTIS with ID 2023-505259-39-00 check the CTIS register for the current data. Primary objectives: • Determine the safety and tolerability • Define the recommended phase 2 dose regimen (RP2D-R) and/or the maximum…